Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin Artwork

AARS Hot Topics

The popular "Hot Topics" newsletter from the American Acne and Rosacea Society (AARS) is now available as a podcast. Listen in for the latest updates on acne, rosacea, and hidradenitis suppurativa and the most recent developments from the Society.

All Episodes

AARS Hot Topics

Hot Topics August 15, 2024: HS Updates, Emergency Contraception and Isotretinoin

August 26, 2024 • American Acne and Rosacea Society (AARS) • Season 1 • Episode 3

In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izokibep, a novel IL-17A inhibitor, for HS, and more.

The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!